Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation
- PMID: 23019293
- PMCID: PMC3500836
- DOI: 10.1161/CIRCULATIONAHA.112.109330
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation
Abstract
Background: Atrial fibrillation is common among older persons. Catheter ablation is increasingly used in patients for whom medical therapy has failed.
Methods and results: We conducted a retrospective cohort study of all fee-for-service Medicare beneficiaries ≥65 years of age who underwent catheter ablation for atrial fibrillation between July 1, 2007, and December 31, 2009. The main outcome measures were major complications within 30 days and mortality, heart failure, stroke, hospitalization, and repeat ablation within 1 year. A total of 15 423 patients underwent catheter ablation for atrial fibrillation. Mean age was 72 years; 41% were women; and >95% were white. For every 1000 procedures, there were 17 cases of hemopericardium requiring intervention, 8 cases of stroke, and 8 deaths within 30 days. More than 40% of patients required hospitalization within 1 year; however, atrial fibrillation or flutter was the primary discharge diagnosis in only 38.4% of cases. Eleven percent of patients underwent repeat ablation within 1 year. Renal impairment (hazard ratio, 2.07; 95% confidence interval, 1.66-2.58), age ≥80 years (hazard ratio, 3.09; 95% confidence interval, 2.32-4.11), and heart failure (hazard ratio, 2.54; 95% confidence interval, 2.07-3.13) were major risk factors for 1-year mortality. Advanced age was a major risk factor for all adverse outcomes.
Conclusions: Major complications after catheter ablation for atrial fibrillation were associated with advanced age but were fairly infrequent. Few patients underwent repeat ablation. Randomized trials are needed to inform risk-benefit calculations for older persons with drug-refractory, symptomatic atrial fibrillation.
Figures




Similar articles
-
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.J Cardiovasc Electrophysiol. 2017 Jan;28(1):39-48. doi: 10.1111/jce.13118. Epub 2016 Dec 5. J Cardiovasc Electrophysiol. 2017. PMID: 27782345 Free PMC article.
-
Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter.Europace. 2016 Apr;18(4):521-30. doi: 10.1093/europace/euv215. Epub 2015 Aug 26. Europace. 2016. PMID: 26311563
-
The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation.J Cardiovasc Electrophysiol. 2016 Feb;27(2):141-6. doi: 10.1111/jce.12849. Epub 2015 Nov 20. J Cardiovasc Electrophysiol. 2016. PMID: 26443666
-
Cardiovascular outcomes of patients with atrial fibrillation and concomitant cardiac amyloidosis undergoing percutaneous catheter ablation.Curr Probl Cardiol. 2025 Mar;50(3):102953. doi: 10.1016/j.cpcardiol.2024.102953. Epub 2024 Dec 2. Curr Probl Cardiol. 2025. PMID: 39631636 Review.
-
Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis.J Interv Card Electrophysiol. 2017 Apr;48(3):307-315. doi: 10.1007/s10840-016-0211-9. Epub 2017 Jan 9. J Interv Card Electrophysiol. 2017. PMID: 28070875 Review.
Cited by
-
Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROAD-DPC Study.J Am Heart Assoc. 2021 Jun;10(11):e019701. doi: 10.1161/JAHA.120.019701. Epub 2021 May 27. J Am Heart Assoc. 2021. PMID: 34041920 Free PMC article.
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation.Clin Pharmacol. 2023 Dec 8;15:113-123. doi: 10.2147/CPAA.S440704. eCollection 2023. Clin Pharmacol. 2023. PMID: 38090388 Free PMC article.
-
Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA.J Interv Card Electrophysiol. 2019 Sep;55(3):243-250. doi: 10.1007/s10840-018-0503-3. Epub 2019 Jan 5. J Interv Card Electrophysiol. 2019. PMID: 30612212
-
Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study.BMC Cardiovasc Disord. 2020 Apr 6;20(1):161. doi: 10.1186/s12872-020-01446-9. BMC Cardiovasc Disord. 2020. PMID: 32252637 Free PMC article.
-
Deep sedation during catheter ablation for atrial fibrillation in elderly patients.J Interv Card Electrophysiol. 2013 Nov;38(2):115-21. doi: 10.1007/s10840-013-9817-3. Epub 2013 Sep 8. J Interv Card Electrophysiol. 2013. PMID: 24013702 Clinical Trial.
References
-
- Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–844. - PubMed
-
- Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D’Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J. 1996;131:790–795. - PubMed
-
- Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953. - PubMed
-
- Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–1046. - PubMed
Publication types
MeSH terms
Grants and funding
- R01HL104156/HL/NHLBI NIH HHS/United States
- R21 DA027021/DA/NIDA NIH HHS/United States
- R01 HL104156/HL/NHLBI NIH HHS/United States
- RC1 HL101056/HL/NHLBI NIH HHS/United States
- R01HL068986/HL/NHLBI NIH HHS/United States
- R01 HL102214/HL/NHLBI NIH HHS/United States
- R21DA027021/DA/NIDA NIH HHS/United States
- K24 HL105780/HL/NHLBI NIH HHS/United States
- R01HL092577/HL/NHLBI NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- R01 HL068986/HL/NHLBI NIH HHS/United States
- K24HL105780/HL/NHLBI NIH HHS/United States
- RC1HL101056/HL/NHLBI NIH HHS/United States
- R01HL102214/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical